Literature DB >> 3011947

Cyclooxygenase blockade elevates leukotriene E4 production during acute anaphylaxis in sheep.

D R Robinson, M Skoskiewicz, K J Bloch, G Castorena, E Hayes, E Lowenstein, C Melvin, F Michelassi, W M Zapol.   

Abstract

We examined changes in the levels of eicosanoids in blood and pulmonary lymph of anesthetized sheep undergoing acute anaphylaxis. Within 1-3 min of intravenous antigenic challenge of previously sensitized sheep, there were approximately 7-30-fold elevations in mean arterial plasma levels of thromboxane B2 and 6-ketoprostaglandin F1 alpha, respectively, as measured by RIA. Negligible changes in levels of these cyclooxygenase products were found in both nonsensitized sheep and in sensitized sheep treated with indomethacin before antigenic challenge. In contrast, no changes in levels of sulfidopeptide leukotrienes (SPLT) in pulmonary lymph were detectable by RIA during anaphylaxis in sensitized or nonsensitized sheep, but levels of SPLT in indomethacin-treated sensitized sheep increased more than fivefold above levels in lymph from both other groups of animals. The immunoreactive SPLT in lymph from indomethacin-treated sheep was accounted for as LTE4, as demonstrated by mobility on HPLC and absorbance at 280 nm. These results support the possibility that certain undesirable effects of nonsteroidal antiinflammatory drugs, such as cardiopulmonary reactions in aspirin-sensitive individuals, and impaired renal and cardiac function during therapy with these drugs, may be related in part to augmented synthesis of the 5-lipoxygenase pathway products, especially those of the sulfidopeptide class. Increased LT production could also limit the antiinflammatory effectiveness of these drugs in many disease states.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011947      PMCID: PMC2188117          DOI: 10.1084/jem.163.6.1509

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Control of vascular permeability by polymorphonuclear leukocytes in inflammation.

Authors:  C V Wedmore; T J Williams
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

2.  Thromboxane B2 (TxB2) release during IgE anaphylaxis in the rabbit.

Authors:  L M McManus; J O Shaw; R N Pinckard
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

3.  Arachidonic acid metabolism by cells in culture: analyses of culture fluids for cyclooxygenase products by radioimmunoassay before and after separation by high pressure liquid chromatography.

Authors:  L Levine; I Alam
Journal:  Prostaglandins Med       Date:  1979-11

4.  Oxidative inactivation of leukotriene C4 by stimulated human polymorphonuclear leukocytes.

Authors:  C W Lee; R A Lewis; E J Corey; A Barton; H Oh; A I Tauber; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

5.  Coronary atherosclerosis in mitral stenosis.

Authors:  P K Chun; E Gertz; J E Davia; M D Cheitlin
Journal:  Chest       Date:  1982-01       Impact factor: 9.410

6.  Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

7.  Effects of leukotriene E on pulmonary mechanics in the guinea pig.

Authors:  J M Drazen; C S Venugopalan; K F Austen; F Brion; E J Corey
Journal:  Am Rev Respir Dis       Date:  1982-03

8.  Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro.

Authors:  J M Drazen; K F Austen; R A Lewis; D A Clark; G Goto; A Marfat; E J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction.

Authors:  F Michelassi; L Landa; R D Hill; E Lowenstein; W D Watkins; A J Petkau; W M Zapol
Journal:  Science       Date:  1982-08-27       Impact factor: 47.728

10.  The actions of leukotrienes C4 and D4 in the porcine renal vascular bed.

Authors:  P J Piper; A W Stanton; L J McLeod
Journal:  Prostaglandins       Date:  1985-01
View more
  7 in total

1.  Severe anaphylactic reaction to diclofenac.

Authors:  Atul A Jha; Vijay Bohra; Vineet Behera
Journal:  Med J Armed Forces India       Date:  2014-11-07

2.  Effects of chronic treatment with indomethacin at clinically relevant doses on intestinal tissue 6-keto prostaglandin F1 alpha and leukotriene B4 level in relation to gastroenteropathy.

Authors:  A Uçar; S D Sak; M Melli
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

3.  Mechanisms underlying the anti-inflammatory activity and gastric safety of acemetacin.

Authors:  A E Chávez-Piña; W McKnight; M Dicay; G Castañeda-Hernández; J L Wallace
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 4.  Treatment of peptic ulcer disease in the arthritic patient.

Authors:  D Nunes; N P Kennedy; D G Weir
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

5.  Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone.

Authors:  A Guhlmann; A Keppler; S Kästner; H Krieter; U B Brückner; K Messmer; D Keppler
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

6.  Diclofenac induced anaphylaxis: A case report from Nepal.

Authors:  Himal Bikram Bhattarai; Sangam Shah; Manish Uprety; Santosh Baniya; Gyabina Maharjan; Anshu Priya; Prabesh Bikram Singh; Ayusha Subedi
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31

7.  Severe Anaphylactic Reaction to Diclofenac during Intravenous Anesthesia for In Vitro Fertilization.

Authors:  Nebojsa Videnovic; Nebojsa Markovic; Jovan Mladenovic; Marija Jovic; Rasa Mladenovic; Ranko Zdravkovic
Journal:  Case Rep Emerg Med       Date:  2019-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.